Now, Russia says its new Covid-19 vaccine Sputnik V is showing over a 92% success rate

The Sputnik V vaccine is developed at the National Research Centre for Epidemiology and Microbiology (NRCEM) in Moscow and is currently going through phase III clinical trials in multiple countries.


Sign Up for nextbigwhat newsletter

Delivered everyday 8 AM. Most comprehensive coverage of the tech ecosystem.

Download, the short news app for busy professionals